TrialLupus science & medicine2021

Risk of psychiatric disorders and all-cause mortality with belimumab therapy in patients with systemic lupus erythematosus: a meta-analysis of randomised controlled trials.

Wenhui Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.